moclobemide has been researched along with Anxiety Neuroses in 8 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Excerpt | Relevance | Reference |
---|---|---|
"To compare the efficacy and tolerability of moclobemide versus paroxetine for the treatment of depression with comorbid anxiety disorders." | 9.10 | Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide. ( Amador, XF; Baldini Rossi, N; Cassano, GB; Cassano, P; Dell'Osso, L; Pini, S; Savino, M, 2003) |
"To compare the efficacy and tolerability of moclobemide versus paroxetine for the treatment of depression with comorbid anxiety disorders." | 5.10 | Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide. ( Amador, XF; Baldini Rossi, N; Cassano, GB; Cassano, P; Dell'Osso, L; Pini, S; Savino, M, 2003) |
"Moclobemide is a specific monoamine oxidase-A inhibitor which does not bind irreversibly to the enzyme, unlike the currently available MAOIs." | 2.67 | An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression. ( Adena, M; Evans, L; George, T; Johnson, G; Mitchell, P; O'Sullivan, B, 1992) |
"Diazepam was a significantly better antidepressant than moclobemide at four week, although not at eight weeks." | 2.66 | Is diazepam an antidepressant? ( Davis, B; Maguire, KP; Schweitzer, I; Tiller, JW, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doruyter, A | 1 |
Dupont, P | 1 |
Taljaard, L | 1 |
Stein, DJ | 2 |
Lochner, C | 1 |
Warwick, JM | 1 |
Cameron, A | 1 |
Amrein, R | 1 |
Montgomery, SA | 1 |
Pini, S | 1 |
Amador, XF | 1 |
Dell'Osso, L | 1 |
Baldini Rossi, N | 1 |
Cassano, P | 1 |
Savino, M | 1 |
Cassano, GB | 1 |
Lapierre, YD | 1 |
Delini-Stula, A | 1 |
Mikkelsen, H | 1 |
Angst, J | 1 |
Clarvit, SR | 1 |
Schneier, FR | 1 |
Liebowitz, MR | 1 |
Evans, L | 1 |
George, T | 1 |
O'Sullivan, B | 1 |
Mitchell, P | 1 |
Johnson, G | 1 |
Adena, M | 1 |
Tiller, JW | 1 |
Schweitzer, I | 1 |
Maguire, KP | 1 |
Davis, B | 1 |
2 reviews available for moclobemide and Anxiety Neuroses
Article | Year |
---|---|
Pharmacological therapy of dysthymia.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzamides; Benzodiazepines; Depressive Disorde | 1994 |
Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzamides; Clinical Trials as | 1995 |
4 trials available for moclobemide and Anxiety Neuroses
Article | Year |
---|---|
Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Drug Administr | 2002 |
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Comorbidity; D | 2003 |
An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
Topics: Adult; Aged; Amitriptyline; Anxiety Disorders; Benzamides; Depressive Disorder; Double-Blind Method; | 1992 |
Is diazepam an antidepressant?
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Arousal; Benzamides; Depressive Disorder; Diazepam; | 1989 |
2 other studies available for moclobemide and Anxiety Neuroses
Article | Year |
---|---|
Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy.
Topics: Adult; Anxiety Disorders; Brain; Brain Mapping; Female; Humans; Magnetic Resonance Imaging; Male; Mi | 2018 |
The offensive subtype of Taijin-kyofu-sho in New York City: the phenomenology and treatment of a social anxiety disorder.
Topics: Adolescent; Adult; Anxiety Disorders; Benzamides; Clonazepam; Culture; Diagnosis, Differential; Ethn | 1996 |